| 产品名称： | Escherichia coli (Migula) Castellani and Chalmers |
|---|---|
| 商品货号： | TS135366 |
| Classification： | Enterobacteriaceae, Escherichia |
| Strain Designations： | B2F1 |
| Application： | Produces Shiga-like toxin II Enteric Research |
| Isolation： | Clinical specimen - human Canada |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Serotype O91:H21 |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 1065: LB Agar/Broth, Miller |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | AD OBrien |
| Chain of Custody： | ATCC < |
| References： | Lindgren SW, et al. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect. Immun. 62: 623-631, 1994. PubMed: 8300218 Lindgren SW, et al. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61: 3832-3842, 1993. PubMed: 8359904 Ito H, et al. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb. Pathog. 8: 47-60, 1990. PubMed: 2185397 Oku Y, et al. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb. Pathog. 6: 113-122, 1989. PubMed: 2654533 patient with hemolytic uremic syndrome, Toronto |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Escherichia coli (Migula) Castellani and Chalmers |
|---|---|
| 商品货号： | TS135366 |
| Classification： | Enterobacteriaceae, Escherichia |
| Strain Designations： | B2F1 |
| Application： | Produces Shiga-like toxin II Enteric Research |
| Isolation： | Clinical specimen - human Canada |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Serotype O91:H21 |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 1065: LB Agar/Broth, Miller |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | AD OBrien |
| Chain of Custody： | ATCC < |
| References： | Lindgren SW, et al. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect. Immun. 62: 623-631, 1994. PubMed: 8300218 Lindgren SW, et al. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61: 3832-3842, 1993. PubMed: 8359904 Ito H, et al. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb. Pathog. 8: 47-60, 1990. PubMed: 2185397 Oku Y, et al. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb. Pathog. 6: 113-122, 1989. PubMed: 2654533 patient with hemolytic uremic syndrome, Toronto |
